Javascript must be enabled to continue!
Molecular Mechanisms Associated with Chromosomal and Microsatellite Instability in Sporadic Glioblastoma multiforme
View through CrossRef
<i>Objective:</i> Two chromosomal instability (CIN) pathways are described in glioblastoma multiforme (GBM), type 1 and type 2, which can be observed in up to 70% of the cases. Microsatellite instability (MSI) plays a pathogenic role in sporadic cancers such as colon, gastric and endometrial carcinomas with deficient mismatch repair (MMR). We aimed to perform a comprehensive analysis of the relationship between CIN and MSI mechanisms in sporadic glioblastomas. <i>Methods:</i> 129 GBMs were examined (109 newly diagnosed and 20 relapses) investigating MSI, immunohistochemical expression of MMR proteins as well as sequencing and promoter methylation of <i>hMLH1</i>. We characterized the molecular changes frequently correlated with CIN in MSI+ GBMs and compared them with 26 microsatellite-stable tumors. <i>Results:</i> Low-level MSI was observed in 11 of 129 (8.5%) cases and was higher in relapses than in primary GBMs (25 vs. 5.5%, p = 0.027). High-level MSI was not found in any case. A deficient expression of MLH1 and PMS2 without <i>hMLH1</i> inactivation was observed only in one giant cell GBM. 55% of the MSI+ GBMs showed a profile which did not correspond to one of the known CIN pathways. An inverse association was observed between MSI and mutations of both <i>p53 </i>and <i>PTEN</i>. <i>Conclusions:</i> Our data suggest that CIN and MSI contribute to the genomic instability in GBMs via independent pathways. Since MSI was significantly more frequent in relapses, it might play a role in the malignant progression of GBM.
Title: Molecular Mechanisms Associated with Chromosomal and Microsatellite Instability in Sporadic Glioblastoma multiforme
Description:
<i>Objective:</i> Two chromosomal instability (CIN) pathways are described in glioblastoma multiforme (GBM), type 1 and type 2, which can be observed in up to 70% of the cases.
Microsatellite instability (MSI) plays a pathogenic role in sporadic cancers such as colon, gastric and endometrial carcinomas with deficient mismatch repair (MMR).
We aimed to perform a comprehensive analysis of the relationship between CIN and MSI mechanisms in sporadic glioblastomas.
<i>Methods:</i> 129 GBMs were examined (109 newly diagnosed and 20 relapses) investigating MSI, immunohistochemical expression of MMR proteins as well as sequencing and promoter methylation of <i>hMLH1</i>.
We characterized the molecular changes frequently correlated with CIN in MSI+ GBMs and compared them with 26 microsatellite-stable tumors.
<i>Results:</i> Low-level MSI was observed in 11 of 129 (8.
5%) cases and was higher in relapses than in primary GBMs (25 vs.
5.
5%, p = 0.
027).
High-level MSI was not found in any case.
A deficient expression of MLH1 and PMS2 without <i>hMLH1</i> inactivation was observed only in one giant cell GBM.
55% of the MSI+ GBMs showed a profile which did not correspond to one of the known CIN pathways.
An inverse association was observed between MSI and mutations of both <i>p53 </i>and <i>PTEN</i>.
<i>Conclusions:</i> Our data suggest that CIN and MSI contribute to the genomic instability in GBMs via independent pathways.
Since MSI was significantly more frequent in relapses, it might play a role in the malignant progression of GBM.
Related Results
Glioblastoma Multiforme from Diagnosis to Rehabilitation: a Prospective, Hospital- Based, Case Study of Inpatient Reported Symptoms, Physiotherapy and Functional Improvement
Glioblastoma Multiforme from Diagnosis to Rehabilitation: a Prospective, Hospital- Based, Case Study of Inpatient Reported Symptoms, Physiotherapy and Functional Improvement
A physiotherapist treats patients with Glioblastoma multiforme. Glioblastoma multiforme treatment includes chemotherapy, radiotherapy, and surgery, which are being continuously dev...
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
Abstract
Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a ...
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract
Background: The standard therapy for glioblastoma patients is tumor resection followed by radiotherapy and temozolomide chemotherapy. Although glioblastoma ...
P10.36.B ROLE OF AMPK IN GLIOBLASTOMA BIOENERGETICS
P10.36.B ROLE OF AMPK IN GLIOBLASTOMA BIOENERGETICS
Abstract
BACKGROUND
Glioblastoma is the most prevalent and aggressive primary brain tumor. AMP-activated kinase (AMPK), the main...
Intermittent oral cyclosporin for recurrent herpes simplex‐associated erythema multiforme
Intermittent oral cyclosporin for recurrent herpes simplex‐associated erythema multiforme
SUMMARYRecurrent erythema multiforme is one of three distinct clinical subtypes of erythema multiforme. We present a 42‐year‐old man with a 10‐year history of recurrent herpes simp...
Abstract 2205: Exploring the presence and role of causative viruses in glioblastoma using a multi-omics approach
Abstract 2205: Exploring the presence and role of causative viruses in glioblastoma using a multi-omics approach
Abstract
Glioblastoma (GB) is the most aggressive brain cancer with a poor survival rate. While molecular markers have been established to improve treatment response...
Numerical prediction of sporadic E layer occurrence using GAIA
Numerical prediction of sporadic E layer occurrence using GAIA
Abstract
A sporadic E layer has significant influence on radio communications and broadcasting, and predicting the occurrence of sporadic E layers is one of the most import...
Prognostic factors and survival of recurrent glioblastoma: a systematic review
Prognostic factors and survival of recurrent glioblastoma: a systematic review
Introduction: Glioblastoma is a highly aggressive brain cancer with poor prognosis. Recurrence is common, and survival post-recurrence is limited. Identifying prognostic factors fo...

